23.11
0.61%
0.14
Handel nachbörslich:
23.11
Schlusskurs vom Vortag:
$22.97
Offen:
$23.05
24-Stunden-Volumen:
33,116
Relative Volume:
1.20
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.46%
1M Leistung:
-6.10%
6M Leistung:
-4.43%
1J Leistung:
+15.09%
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Firmenname
Ishares Genomics Immunology And Healthcare Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IDNA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
IDNA | 23.11 | 0 | 0 | 0 | 0 | 0.00 |
VTI | 291.49 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY | 588.15 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV | 591.11 | 253.41B | 0 | 0 | 0 | 0.00 |
VB | 247.33 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ | 500.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Aktie (IDNA) Neueste Nachrichten
Future Health: Harnessing Innovations In Healthcare - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Quotes, Forecast and News Summary - Benzinga
iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1114 - MSN
7 Best Biotech ETFs In Canada for September 2024 - Wealth Awesome
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
Moderna ETFs to Rally on Positive COVID-19 Booster Shot News - Yahoo News UK
IDNA ETF: Healthcare Dashboard For February - Seeking Alpha
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Finance
Has Biotechnology Bottomed Out? - Master Investor
2024 Market Forecast: 3 Key Trends in the Healthcare Industry - InvestorPlace
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
Which Pharma Stocks Are Relying on Immunology for Future Growth? - Opto RoW
IDNA: Continues To Underperform, But With Long-Term Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - Yahoo Finance
Noticeable performance for Healthcare and Biotech ETFs - Trackinsight
RBC iShares Opens the Market - Canada NewsWire
Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility - Investing.com India
Vir Jumps 20% On S&P SmallCap 600 News - Yahoo Finance
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Invest in the Future With Megatrend ETFs - Yahoo Canada Shine On
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Launches Megatrend ETF Suite Designed to Capture Five Transformational Long-Term Trends - Business Wire
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
ARK Genomic Revolution ETF - ETFdb.com
Editas Medicine (EDIT) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Ishares Genomics Immunology And Healthcare Etf-Aktie (IDNA)
Es liegen keine Finanzdaten für Ishares Genomics Immunology And Healthcare Etf (IDNA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):